Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANIDULAFUNGIN
- A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
- Azole-echinocandin Combination Therapy for Invasive Aspergillosis
- Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)
- Negative Beta Glucan in ICU Patients
- Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
- Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
- Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
- Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
- Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
- A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
- Anidulafungin in Patients With Hematologic Malignancies
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
- Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
- Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida
- Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
- Anidulafungin PK in Infants and Toddlers
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
- Anidulafungin In Treatment Of Candidemia In Asian Subjects
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
- Antimicrobial PK in Infants With Suspected or Confirmed Infection
- Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
- Anidulafungin in Treating Immunocompromised Children With Neutropenia
- Anidulafungin Versus Fluconazole in the Treatment of Candidemia
- Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
- The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
- The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)
- The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
Clinical trials list
click for details